Table 2 APRICOT-M performance for 4-h predictions in terms of AUROC for three study cohorts

Primary

Discharge

0.85 (0.85–0.86)

0.85 (0.85–0.85)

0.86 (0.82–0.90)

Stable

0.91 (0.91–0.91)^c

0.87 (0.87–0.87)^a,c

0.92 (0.91–0.92)^a,b

Unstable

0.92 (0.92–0.92)

0.88 (0.88–0.88)^a,c

0.92 (0.92–0.93)^b

Deceased

0.94 (0.94–0.95)^b,c

0.95 (0.94–0.95)^a,c

0.99 (0.96–1.00)^a,b

Transition

Unstable–stable

0.77 (0.76–0.77)^b

0.70 (0.70–0.70)^a

0.73 (0.69–0.77)

Stable–unstable

0.77 (0.76–0.77)^c

0.77 (0.77–0.77)^c

0.71 (0.67–0.75)^a,b

Life-sustaining therapy

MV

0.80 (0.79–0.81)^c

0.81 (0.80–0.81)^c

0.73 (0.69–0.77)^a,b

VP

0.81 (0.80–0.82)^b

0.76 (0.76–0.77)^a,c

0.83 (0.78–0.87)^b

CRRT

0.94 (0.93–0.96)^b

0.86 (0.85–0.87)^a

0.93 (0.79–0.98)